Sarepta Therapeutics
SRPT
#1424
Rank
$12.06 B
Marketcap
$128.57
Share price
-1.27%
Change (1 day)
-1.96%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : $2.40 B

According to Sarepta Therapeutics 's latest financial reports the company's total liabilities are $2.40 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sarepta Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31$2.40 B-12.33%
2022-12-31$2.74 B23.58%
2021-12-31$2.21 B-0.13%
2020-12-31$2.22 B121.27%
2019-12-31$1.00 B64.75%
2018-12-31$0.60 B17.55%
2017-12-31$0.51 B493.44%
2016-12-31$87.41 M4.77%
2015-12-31$83.43 M76.1%
2014-12-31$47.38 M6.77%
2013-12-31$44.37 M-45.43%
2012-12-31$81.31 M248.22%
2011-12-31$23.35 M-52.14%
2010-12-31$48.79 M34.06%
2009-12-31$36.39 M271.25%
2008-12-31$9.8 M-20.01%
2007-12-31$12.25 M288.98%
2006-12-31$3.15 M14.66%
2005-12-31$2.74 M22.15%
2004-12-31$2.24 M-40.03%
2003-12-31$3.75 M-26.77%
2002-12-31$5.12 M56.11%
2001-12-31$3.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$39.37 B 1,537.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.71 B 12.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.51 B 4.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.05 B 68.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.66 B-30.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.97 B-59.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.12 B-94.69%๐Ÿ‡บ๐Ÿ‡ธ USA